Skip to: Curated Story Group 1
Visually Open Nav.
Advertise
with us
US
EUROPE
APAC
CANADA
LATAM
subscribe
Open Search Field.
Home
Topics
Biomanufacturing
Biomanufacturing
Biomanufacturing
Biomanufacturing
Biomanufacturing
Business Services
Business Services
Business Services
Business Services
Business Services
Drug Discovery
Drug Discovery
Drug Discovery
Drug Discovery
Drug Discovery
Pharmacy Management
Regulatory Services
CXO Insights
Vendor Viewpoint
News
Conferences
Newsletter
Whitepapers
Magazine
CXO Awards
JULY 2021LIFE SCIENCES REVIEW6The biotech sector in the Asia Pacific region is booming. Innovative companies are emerging to increase access to healthcare through digital technologies. At the same time, genomics and ophthalmology are key areas of growth. The industry is adopting trends like artificial intelligence (AI), data analytics, and automation to optimize production, and there is a sharp rise in consumer biotech products targeted directly at customers instead of biopharma or healthcare businesses. Moreover, the sector is undertaking a data-driven approach that can create value across the supply chain, manufacturing, and the entire healthcare ecosystem. With disruptive tech is growing exponentially with some predicting an increase of 400 percent over the next five years and biotech is one of the major industries to watch through 2021.Medical technology is becoming increasingly sophisticated. And one critical development that will start to shape the industry over the next decade is biosensors. Calibrated and designed to track various biosignatures such as blood pressure, pulse, breathing, and body temperature, biosensors will revolutionize how we monitor our health. There has been an explosion of AI startups and tech giants in the APAC who are contributing to the advances in AI-driven biotechnology that is expected to lead to new developments. Such technological developments are creating a shift to cure rare diseases. Biotechnological innovations have grown steadily in the past ten years, not only in the medical arenas but also in the agriculture, environment, and energy sectors. Today, single-cell technologies provide detailed views of cellular environments and are essential tools for drug discovery and clinical research. Furthermore, with several projects in the pipeline, the biotech industry is bracing for development through the years.In this edition of Life Sciences Review, we bring you the story of some of the most prominent organizations specializing in biotechnology and are a significant driver of the key trends and strategies. To shed light on these organizations, Life Science Review has created a list of Top 10 Biotech Startups in APAC 2021. These providers are transforming the biotech landscape with their best-in-class solutions. Besides, the magazine comprises insights from subject-matter experts, CIOs, CXOs in the logistics sector on the latest industry trends, best practices, recent innovations, and expertise.Let us know your thoughts.EDITORIALTech Advancements Improving Care DeliveryCopyright © 2021 ValleyMedia, Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.Contact Us:Phone:510-230-0395Fax:510-894-8405Email:sales@lifesciencesreview.comeditor@lifesciencesreview.commarketing@lifesciencesreview.com July - 09 - 2021, Vol 02, Issue - 03 Published by ValleyMedia, Inc.To subscribe to Life Sciences ReviewVisit www.lifesciencesreview.com Editorial StaffAaron PierceCarolynn WaltersShirley FaithRussell ThomasVisualizersRonald Donovan*Some of the Insights are based on the interviews with respective CIOs and CXOs to our editorial staffJeremy WilliamsManaging Editoreditor@lifesciencesreview.comManaging EditorJeremy WilliamsSalesStephen Thomassales@lifesciencesreview.comAsher Blake
<
Page 5
|
Page 7
>